Related Experiment Video
Updated: Jun 10, 2026

Influenza A Virus Studies in a Mouse Model of Infection
Published on: September 7, 2017
PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus
Jihui Ping1, Samar K Dankar, Nicole E Forbes
1Department of Biochemistry, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada K1H 8M5.
Abstract:
Serial mouse lung passage of a human influenza A virus, A/Hong Kong/1/68 (H3N2) (HK-wt), produced a mouse-adapted variant, MA, with nine mutations that was >10(3.8)-fold more virulent. In this study, we demonstrate that MA mutations of the PB2 (D701N) and hemagglutinin (HA) (G218W in HA1 and T156N in HA2) genes were the most adaptive genetic determinants for increased growth and virulence in the mouse model. Recombinant viruses expressing each of the mutated MA genome segments on the HK-wt backbone showed significantly increased disease severity, whereas only the mouse-adapted PB2 gene increased virulence, as determined by the 50% lethal dose ([LD(50)] >10(1.4)-fold). The converse comparisons of recombinant MA viruses expressing each of the HK-wt genome segments showed the greatest decrease in virulence due to the HA gene (10(2)-fold), with lesser decreases due to the M1, NS1, NA, and PB1 genes (10(0.3)- to 10(0.8)-fold), and undetectable effects on the LD(50) for the PB2 and NP genes. The HK PB2 gene did, however, attenuate MA infection, as measured by weight loss and time to death. Replication of adaptive mutations in vivo and in vitro showed both viral gene backbone and host range effects. Minigenome transcription assays showed that PB1 and PB2 mutations increased polymerase activity and that the PB2 D701N mutation was comparable in effect to the mammalian adaptive PB2 E627K mutation. Our results demonstrate that host range and virulence are controlled by multiple genes, with major roles for mutations in PB2 and HA.
Insights
Influenza A virus adaptation to mice involves mutations in PB2 and hemagglutinin (HA) genes, significantly increasing virulence. These genetic changes enhance viral growth and polymerase activity, demonstrating multi-gene control over host range and pathogenicity.
Area of Science:
- Virology
- Molecular Biology
- Pathogenesis
Background:
- Influenza A virus adaptation to new hosts is a complex process involving genetic mutations.
- Serial passage of human influenza A virus (H3N2) in mice generated a highly virulent variant (MA).
Purpose of the Study:
- To identify the specific genetic determinants responsible for increased virulence and mouse adaptation of influenza A virus.
- To elucidate the roles of individual viral genes in host range and pathogenicity.
Main Methods:
- Generation of a mouse-adapted influenza A virus variant through serial lung passage.
- Construction and characterization of recombinant viruses with specific gene segment mutations.
- Assessment of viral virulence using 50% lethal dose (LD50) and clinical signs (weight loss, time to death).
- In vitro minigenome transcription assays to evaluate polymerase activity.
Main Results:
- Mutations in the PB2 (D701N) and hemagglutinin (HA) genes were identified as key determinants of increased mouse virulence.
- Recombinant viruses with MA PB2 or HA genes showed significantly increased disease severity.
- The PB2 D701N mutation conferred increased virulence comparable to the known mammalian adaptive mutation PB2 E627K.
- Other gene segments (M1, NS1, NA, PB1) contributed to virulence attenuation when reverted to the wild-type sequence.
Conclusions:
- Host range and virulence of influenza A virus are controlled by multiple viral genes, with PB2 and HA playing major roles.
- Specific mutations in PB2 and HA are critical for efficient viral replication and pathogenicity in a new host.
- Understanding these adaptive mutations provides insights into influenza virus evolution and pandemic potential.
More Related Videos
Related Concept Videos
Leaky Scanning
Influenza
Inhibitors Of Virion Release
Viral Mutations
Viral Recombination
Viruses with RNA Genomes

